The MDM2-binding Region in the Transactivation Domain of P53 Also Acts As a Bcl-X(L)-binding Motif.
Roy S. Herbst,Yi-Long Wu,Thomas John,Christian Grohe,Margarita Majem,Jie Wang,Terufumi Kato,Jonathan W. Goldman,Konstantin Laktionov,Sang-We Kim,Chong-Jen Yu,Huu Vinh Vu,Shun Lu,Kye Young Lee,Guzel Mukhametshina,Charuwan Akewanlop,Filippo de Marinis,Laura Bonanno,Manuel Domine,Frances A. Shepherd,Damien Urban,Xiangning Huang,Ana Bolanos,Marta Stachowiak,Masahiro Tsuboi
DOI: https://doi.org/10.1021/bi901188s
IF: 3.321
2009-01-01
Biochemistry
Abstract:While the transcription-dependent mechanism of p53 has been extensively studied, recently the transcription-independent apoptotic activity of p53 has also been described. Bcl-2 and Bcl-X(L) interact with p53 and induce apoptosis. Initially, the p53 DNA-binding domain (p53DBD) was found to bind to Bcl-2 and Bcl-X(L). Later, the p53 N-terminal domain (p53NTD) was reported to be sufficient for inducing the transcription-independent apoptotic activity of p53 and also shown to interact with Bcl-X(L). Here, we further document that the transactivation domain of p53 (p53TAD) in p53NTD alone binds to Bcl-X(L). We demonstrated that the MDM2-binding region (residues S15 to N29, herein referred to as SN15) in p53TAD is the binding site for Bcl-X(L). The binding interface on Bcl-X(L) was identified at the hydrophobic pocket formed by the BH1, BH2, and BH3 domains, which also binds to the Bak/Bad BH3 peptides, suggesting Bcl-X(L) and MDM2 share a common binding motif in p53TAD. Our NMR structural studies have shown that the SN15 peptide undergoes a conformational change upon binding to Bcl-X(L). A Bcl-X(L)/SN15 complex structural model suggests that the SN15 peptide adopts an extended alpha-helical structure to bind to the hydrophobic pocket on the Bcl-X(L), which is similar to the mode of binding between BH3 peptides and Bcl-X(L).